Pharmaceutical News

RSS

Epidural pain relief with fentanyl during childbirth does not affect early breastfeeding success

Including the opioid fentanyl in the solution used to maintain an epidural during childbirth does not appear to affect the success of breastfeeding six weeks after delivery, according to a study published in Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists. Previous research has suggested fentanyl might be associated with early termination of breastfeeding.

8 Nov 2017

Novel approach could help predict how well patients respond to cancer treatment

A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.

8 Nov 2017

Advances in needle-free flu vaccination methods show promise

Autumn has arrived, leaves are changing colors, and pumpkin spice aromas are sweeping stores. It's also the season for flu shots. The good news is that the annual jab in the arm designed to protect us from the flu might one day be a thing of the past.

8 Nov 2017

UNSW study examines effect of drug on negative effects of maternal obesity

A drug that increases energy metabolism may lead to a new approach to prevent obesity in children born to overweight mothers, UNSW Sydney researchers have found.

8 Nov 2017

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes, or fat cells, can absorb and metabolize the chemotherapeutic agent daunorubicin, reducing the effectiveness of the drug and potentially contributing to poorer treatment outcomes.

8 Nov 2017

New discovery in beta-cell pathway shows potential to improve effectiveness of diabetes drugs

Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes.

8 Nov 2017

Major labeling inaccuracies in cannabidiol extract products

There is a growing demand among consumers for marijuana containing products supposedly providing several health benefits in a range od diseases and conditions. This has spawned thousands of websites that are selling these products online. Many of these contain mislabeled cannabidiol (CBD) or a compound found in cannabis or marijuana finds a new study.

7 Nov 2017

Study finds mislabeling in nearly 70% of cannabidiol products sold online

In recent years, there has been an increased interest in the medicinal use of Cannabidiol (CBD), a chemical that naturally occurs the in cannabis plant (aka "marijuana"). There is interest in CBD as a medicine because there is some evidence that it has medical benefits,

7 Nov 2017

Mislabeling of cannabidiol products poses safety and efficacy issues for consumers

Growing consumer demand for cannabis-related products purported to have medicinal benefits has created an environment where people are using mislabeled cannabidiol products sold online.

7 Nov 2017

Ohio’s drug-pricing ballot question triggers voter confusion

Lawmakers in the nation's capital have yet to grapple with rising drug costs, but Ohio voters are being asked — in a single ballot-box question next week — to figure out how best to lower the tab the state pays for prescriptions.

7 Nov 2017

New study finds enhanced impact of drug combination for FAP patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care.

7 Nov 2017

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).

7 Nov 2017

Research examines trend in hospitalizations from opioid poisonings

Preliminary research presented today at APHA's 2017 Annual Meeting and Expo examined the trend in hospitalizations from opioid poisonings in West Virginia, a state heavily impacted by the current opioid overdose crisis.

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Common antidepressants may not work for depressed patients with chronic kidney disease

Scientists are finding more evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Quorum sensing data presented at the North American Cystic Fibrosis Conference by Neem Biotech

Neem Biotech, the Welsh-based fundamental Research and Development arm of the Zaluvida group of life science companies, was pleased to present the work into development of a novel mode of action as an adjunct to existing antibiotics at the North American Cystic Fibrosis Conference Indiana, USA from 2nd November 2017 to 4th of November 2017.

From Neem Biotech 6 Nov 2017

Biologics do not raise risk of second cancer diagnosis in RA patients

Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.

6 Nov 2017

Study shows link between use of reflux medications and increased risk of CKD, kidney failure

A recent analysis has linked certain medications commonly used to treat heartburn, acid reflux, and ulcers with the development of kidney disease. The findings will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.

6 Nov 2017

Many patients with knee, hip and spine osteoarthritis use opioids to manage chronic pain

A large percentage of patients with end-stage knee, hip and spine osteoarthritis use opioids to manage their chronic pain, especially those who are younger or have symptoms of depression, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Pharmaceutical News

Epidural pain relief with fentanyl during childbirth does not affect early breastfeeding success

Novel approach could help predict how well patients respond to cancer treatment

Advances in needle-free flu vaccination methods show promise

UNSW study examines effect of drug on negative effects of maternal obesity

Adipocytes may reduce effectiveness of chemotherapeutic drug

New discovery in beta-cell pathway shows potential to improve effectiveness of diabetes drugs

Major labeling inaccuracies in cannabidiol extract products

Study finds mislabeling in nearly 70% of cannabidiol products sold online

Mislabeling of cannabidiol products poses safety and efficacy issues for consumers

Ohio’s drug-pricing ballot question triggers voter confusion

New study finds enhanced impact of drug combination for FAP patients

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

Research examines trend in hospitalizations from opioid poisonings

FDA grants approval to first treatment for rare blood cancer

Common antidepressants may not work for depressed patients with chronic kidney disease

FDA approves new drug Zelboraf for Erdheim-Chester disease

Quorum sensing data presented at the North American Cystic Fibrosis Conference by Neem Biotech

Biologics do not raise risk of second cancer diagnosis in RA patients

Study shows link between use of reflux medications and increased risk of CKD, kidney failure

Many patients with knee, hip and spine osteoarthritis use opioids to manage chronic pain

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News